• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医生说你不能使用[丁丙诺啡]:自主使用处方或非处方丁丙诺啡。

"The Doctor Says You Cannot Have [Buprenorphine]" Autonomy and Use of Prescribed or Non-Prescribed Buprenorphine.

机构信息

Division44 of General Internal Medicine, Montefiore Medical Center, Bronx, NY, USA.

New York Harm Reduction Educators, New York, NY, USA.

出版信息

Subst Use Misuse. 2021;56(8):1137-1143. doi: 10.1080/10826084.2021.1908360. Epub 2021 May 3.

DOI:10.1080/10826084.2021.1908360
PMID:33939937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8754088/
Abstract

BACKGROUND

People may overcome barriers to professional buprenorphine treatment by using non-prescribed buprenorphine (NPB) to manage opioid use disorder (OUD). Little is known about how people perceive NPB differently than formal treatment. This qualitative study investigated how and why people use NPB as an alternative to formal treatment.

METHODS

In-depth, semi-structured interviews were conducted with participants of harm reduction agencies (=22) who had used buprenorphine. Investigators independently coded transcribed interviews, generating themes through iterative reading and analysis of transcripts.

RESULTS

Three main factors drove decisions about prescribed and non-prescribed buprenorphine use: 1) autonomy; 2) treatment goals; and 3) negative early experiences with NPB. An overarching theme from our analysis was that participants valued autonomy in seeking to control their substance use. NPB was a valuable tool toward this goal and professional OUD treatment could impede autonomy. Participants mostly used NPB to "self-manage" OUD symptoms. Many participants had concerns about long-term buprenorphine treatment and instead used NPB over short periods of time. Several participants also reported negative experiences with NPB, including symptoms of withdrawal, which then deterred them from seeking out professional treatment.

CONCLUSIONS

These results support prior studies showing that people use NPB to self-manage withdrawal symptoms and to reduce use of illicit opioids. Despite these benefits, participants focused on short-term goals and negative consequences were common. Increasing buprenorphine treatment engagement may require attention to patients' sense of autonomy, and also assurance that long-term treatment is safe, effective, and reliably accessible.

摘要

背景

人们可能会通过使用非处方丁丙诺啡(NPB)来管理阿片类药物使用障碍(OUD),从而克服专业丁丙诺啡治疗的障碍。人们对 NPB 与正规治疗的看法不同,这方面知之甚少。这项定性研究调查了人们如何以及为何将 NPB 用作正规治疗的替代方法。

方法

对参加减少伤害机构的参与者(=22)进行了深入的半结构化访谈,这些参与者曾使用过丁丙诺啡。调查人员独立对转录的访谈进行编码,通过对转录本的反复阅读和分析生成主题。

结果

决定使用处方和非处方丁丙诺啡的三个主要因素是:1)自主性;2)治疗目标;3)对 NPB 的早期负面体验。我们分析的一个首要主题是,参与者重视寻求控制自己的药物使用的自主权。NPB 是实现这一目标的宝贵工具,而专业的 OUD 治疗可能会妨碍自主性。参与者主要使用 NPB 来“自我管理”OUD 症状。许多参与者对长期丁丙诺啡治疗表示担忧,因此选择短期使用 NPB。一些参与者还报告了对 NPB 的负面体验,包括戒断症状,这使他们不愿寻求专业治疗。

结论

这些结果支持了先前的研究,表明人们使用 NPB 来自我管理戒断症状并减少非法阿片类药物的使用。尽管有这些好处,但参与者关注短期目标,负面后果很常见。增加丁丙诺啡治疗的参与度可能需要关注患者的自主权意识,同时确保长期治疗是安全、有效且可靠的。

相似文献

1
"The Doctor Says You Cannot Have [Buprenorphine]" Autonomy and Use of Prescribed or Non-Prescribed Buprenorphine.医生说你不能使用[丁丙诺啡]:自主使用处方或非处方丁丙诺啡。
Subst Use Misuse. 2021;56(8):1137-1143. doi: 10.1080/10826084.2021.1908360. Epub 2021 May 3.
2
On my own terms: Motivations for self-treating opioid-use disorder with non-prescribed buprenorphine.按自己的条件:非处方丁丙诺啡自我治疗阿片类药物使用障碍的动机。
Drug Alcohol Depend. 2020 May 1;210:107958. doi: 10.1016/j.drugalcdep.2020.107958. Epub 2020 Mar 16.
3
Patterns of non-prescribed buprenorphine and other opioid use among individuals with opioid use disorder: A latent class analysis.阿片类物质使用障碍人群中超处方丁丙诺啡和其他阿片类物质使用模式:潜在类别分析。
Drug Alcohol Depend. 2019 Nov 1;204:107574. doi: 10.1016/j.drugalcdep.2019.107574. Epub 2019 Sep 22.
4
Trajectories of non-prescribed buprenorphine and other opioid use: A multi-trajectory latent class growth analysis.非处方丁丙诺啡和其他阿片类药物使用轨迹:多轨迹潜在类别增长分析。
J Subst Use Addict Treat. 2023 Apr;147:208973. doi: 10.1016/j.josat.2023.208973. Epub 2023 Feb 10.
5
Non-Prescribed Substance Use during the First Month of Treatment by People Receiving Depot Buprenorphine for Opioid Use Disorder.接受长效丁丙诺啡纳洛酮治疗的阿片类药物使用障碍患者在治疗的第一个月内非处方物质的使用情况。
Subst Use Misuse. 2023;58(13):1696-1706. doi: 10.1080/10826084.2023.2244064. Epub 2023 Aug 12.
6
"They're making it so hard for people to get help:" Motivations for non-prescribed buprenorphine use in a time of treatment expansion.“他们让人们获得帮助变得如此困难:”在治疗扩张时期非处方丁丙诺啡使用的动机。
Int J Drug Policy. 2019 Sep;71:118-124. doi: 10.1016/j.drugpo.2019.06.019. Epub 2019 Jul 20.
7
Non-prescribed buprenorphine preceding treatment intake and clinical outcomes for opioid use disorder.非处方丁丙诺啡在阿片类药物使用障碍治疗前使用与临床结局。
J Subst Abuse Treat. 2022 Aug;139:108770. doi: 10.1016/j.jsat.2022.108770. Epub 2022 Mar 21.
8
Does incarceration influence patients' goals for opioid use disorder treatment? A qualitative study of buprenorphine treatment in jail.监禁是否会影响患者治疗阿片类药物使用障碍的目标?对监狱中丁丙诺啡治疗的定性研究。
Drug Alcohol Depend. 2021 May 1;222:108529. doi: 10.1016/j.drugalcdep.2021.108529. Epub 2021 Mar 18.
9
Buprenorphine in the United States: Motives for abuse, misuse, and diversion.丁丙诺啡在美国:滥用、误用和转移的动机。
J Subst Abuse Treat. 2019 Sep;104:148-157. doi: 10.1016/j.jsat.2019.07.005. Epub 2019 Jul 12.
10
Challenges on the road to recovery: Exploring attitudes and experiences of clients in a community-based buprenorphine program in Baltimore City.康复之路上的挑战:探索巴尔的摩市社区美沙酮项目中客户的态度和体验。
Addict Behav. 2019 Jun;93:14-19. doi: 10.1016/j.addbeh.2019.01.020. Epub 2019 Jan 17.

引用本文的文献

1
Pain Neuroscience Education on Reducing Opioid Dependency in African American and Caucasian Populations: A Narrative Review.疼痛神经科学教育对减少非裔美国人和白种人群阿片类药物依赖的作用:一项叙述性综述
J Clin Med. 2025 Jun 19;14(12):4360. doi: 10.3390/jcm14124360.
2
Real-world access to buprenorphine treatment in Philadelphia: A secret shopper study.费城丁丙诺啡治疗的实际可及性:一项暗访研究。
Drug Alcohol Depend. 2025 Mar 1;268:112586. doi: 10.1016/j.drugalcdep.2025.112586. Epub 2025 Jan 29.
3
Low-dose buprenorphine initiation and treatment continuation among hospitalized patients with opioid dependence: A retrospective cohort study.低剂量丁丙诺啡起始治疗和住院阿片类药物依赖患者的治疗维持:一项回顾性队列研究。
J Subst Use Addict Treat. 2024 Mar;158:209261. doi: 10.1016/j.josat.2023.209261. Epub 2023 Dec 14.
4
Examining buprenorphine diversion through a harm reduction lens: an agent-based modeling study.从减少伤害的角度审视丁丙诺啡的滥用:基于代理的建模研究。
Harm Reduct J. 2023 Oct 17;20(1):150. doi: 10.1186/s12954-023-00888-6.
5
Urine Drug Screening in a Telehealth Setting for the Treatment of Opioid Use Disorder.远程医疗环境中的尿液药物筛查用于治疗阿片类药物使用障碍。
JAMA Health Forum. 2023 Jul 7;4(7):e232247. doi: 10.1001/jamahealthforum.2023.2247.
6
Trajectories of non-prescribed buprenorphine and other opioid use: A multi-trajectory latent class growth analysis.非处方丁丙诺啡和其他阿片类药物使用轨迹:多轨迹潜在类别增长分析。
J Subst Use Addict Treat. 2023 Apr;147:208973. doi: 10.1016/j.josat.2023.208973. Epub 2023 Feb 10.
7
Buprenorphine involvement in opioid overdose deaths: A retrospective analysis of postmortem toxicology in Marion County, Indiana, 2015-2021.丁丙诺啡与阿片类药物过量死亡的关系:对2015 - 2021年印第安纳州马里恩县尸检毒理学的回顾性分析。
Drug Alcohol Depend Rep. 2023 Mar;6. doi: 10.1016/j.dadr.2023.100131. Epub 2023 Jan 4.
8
Non-prescribed buprenorphine preceding treatment intake and clinical outcomes for opioid use disorder.非处方丁丙诺啡在阿片类药物使用障碍治疗前使用与临床结局。
J Subst Abuse Treat. 2022 Aug;139:108770. doi: 10.1016/j.jsat.2022.108770. Epub 2022 Mar 21.

本文引用的文献

1
On my own terms: Motivations for self-treating opioid-use disorder with non-prescribed buprenorphine.按自己的条件:非处方丁丙诺啡自我治疗阿片类药物使用障碍的动机。
Drug Alcohol Depend. 2020 May 1;210:107958. doi: 10.1016/j.drugalcdep.2020.107958. Epub 2020 Mar 16.
2
Defining Low-threshold Buprenorphine Treatment.定义低门槛丁丙诺啡治疗。
J Addict Med. 2020 Mar/Apr;14(2):95-98. doi: 10.1097/ADM.0000000000000555.
3
"Everything is not right anymore": Buprenorphine experiences in an era of illicit fentanyl.“一切都不再正常了”:非法芬太尼时代的丁丙诺啡体验。
Int J Drug Policy. 2019 Dec;74:76-83. doi: 10.1016/j.drugpo.2019.09.003. Epub 2019 Sep 25.
4
Conceptualizing patient-centered care for substance use disorder treatment: findings from a systematic scoping review.概念化以患者为中心的物质使用障碍治疗方法:系统范围综述的结果。
Subst Abuse Treat Prev Policy. 2019 Sep 11;14(1):37. doi: 10.1186/s13011-019-0227-0.
5
Engaging an unstably housed population with low-barrier buprenorphine treatment at a syringe services program: Lessons learned from Seattle, Washington.在一个注射器服务项目中为住房不稳定人群提供低门槛丁丙诺啡治疗:来自华盛顿州西雅图市的经验教训。
Subst Abus. 2020;41(3):356-364. doi: 10.1080/08897077.2019.1635557. Epub 2019 Aug 12.
6
Buprenorphine in the United States: Motives for abuse, misuse, and diversion.丁丙诺啡在美国:滥用、误用和转移的动机。
J Subst Abuse Treat. 2019 Sep;104:148-157. doi: 10.1016/j.jsat.2019.07.005. Epub 2019 Jul 12.
7
"They're making it so hard for people to get help:" Motivations for non-prescribed buprenorphine use in a time of treatment expansion.“他们让人们获得帮助变得如此困难:”在治疗扩张时期非处方丁丙诺啡使用的动机。
Int J Drug Policy. 2019 Sep;71:118-124. doi: 10.1016/j.drugpo.2019.06.019. Epub 2019 Jul 20.
8
Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?在医疗实践中开具丁丙诺啡治疗阿片类药物使用障碍:基于诊室的门诊治疗能否解决美国的阿片类药物危机?
Addiction. 2019 Nov;114(11):1992-1999. doi: 10.1111/add.14733. Epub 2019 Jul 25.
9
Buprenorphine Treatment Divide by Race/Ethnicity and Payment.美沙酮治疗按种族/民族和支付方式划分。
JAMA Psychiatry. 2019 Sep 1;76(9):979-981. doi: 10.1001/jamapsychiatry.2019.0876.
10
Low barrier buprenorphine treatment for persons experiencing homelessness and injecting heroin in San Francisco.在旧金山为无家可归并注射海洛因的人群提供低门槛丁丙诺啡治疗。
Addict Sci Clin Pract. 2019 May 6;14(1):20. doi: 10.1186/s13722-019-0149-1.